Latest News about BIIB
Recent news which mentions BIIB
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
From Benzinga
From Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
May 11, 2022
From Motley Fool
From Benzinga
From Benzinga
Tickers
BIIB
From Motley Fool
1 Reason to Buy Biogen Now, and 1 Reason to Wait
May 05, 2022
From Motley Fool
10 Biggest Price Target Changes For Wednesday
May 04, 2022
From Benzinga
From MarketWatch
Tickers
BIIB
From InvestorPlace
From MarketWatch
From Benzinga
Stocks may keep sliding until institutions join retail investors in capitulation, this firm says
May 03, 2022
From MarketWatch
From MarketWatch
Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder
May 02, 2022
From Benzinga
From Benzinga
These 21 large-cap stocks have now crashed at least 50%
April 26, 2022
From MarketWatch
Is This Biotech Stock Worth the Trouble?
April 23, 2022
From Motley Fool
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
April 23, 2022
From Motley Fool
Is Biogen Stock a Buy Now?
April 21, 2022
From Motley Fool
Down 16% Since October, Could This Stock Make a Turnaround?
April 21, 2022
Tickers
BIIB
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.